Furthermore, flow cytometry analysis revealed that knockdown of IGF2BP3 elevated the proportion of G1 phase cells in bladder cancer cells; on the contrary, overexpression of IGF2BP3 exhibited an opposite trend (Figure 3E-F). The gene discussed is IGF2BP3; the disease is urinary bladder carcinoma.